Modulators of HIF1α and NFkB in Cancer Treatment: Is It a Rational Approach for Controlling Malignant Progression?

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2013.00013
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Changes of N6-Methyladenosine Modulators Promote Breast Cancer Progression

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Nonalcoholic Fatty Liver Disease: Is It Time for Combination Treatment and a Diabetes-Like Approach?

Hepatology
MedicineHepatology
2018English

Cancer Stem Cell and Its Niche in Malignant Progression of Oral Potentially Malignant Disorders

Oral Oncology
Cancer ResearchOral SurgeryOncology
2017English

A Rational Approach to the Treatment of Ascites

Postgraduate Medical Journal
Medicine
1975English

Allosteric Modulators of GPCRs: A Novel Approach for the Treatment of CNS Disorders

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2009English

Malignant Trichilemmoma. Is It a Type of Senile Keratosis?

Skin Cancer
1989English

Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts

PLoS ONE
Multidisciplinary
2016English

HIF1α and HIF2α: Sibling Rivalry in Hypoxic Tumour Growth and Progression

Nature Reviews Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy